Author(s):
Ismail Bennani, Ali Cherif Chefchaouni, Safae Alaoui, Badreddine Moukafih, Soufiane El Marrakchi, Fatima-Zahra Bandadi, Youssef Hafidi, Younes Rahali, Abdeslam El Kartouti
Email(s):
chefchaouniali@gmail.com
DOI:
10.52711/0974-360X.2025.00048 
Address:
Ismail Bennani1,2, Ali Cherif Chefchaouni3,4, Safae Alaoui1,2, Badreddine Moukafih1,2, Soufiane El Marrakchi1,2, Fatima-Zahra Bandadi1,2, Youssef Hafidi2, Younes Rahali3,4, Abdeslam El Kartouti1
1Department of Pharmacy, Faculty of Medicine, Pharmacy, and Dental Medicine of Fez, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
2Department of Pharmacy, Hassan II University Hospital of Fez, Morocco.
3Faculty of Medicine and Pharmacy, Mohammed V University of Rabat, Rabat, Morocco.
4Ibn Sina University Hospital Center, Rabat, Morocco.
*Corresponding Author
Published In:
Volume - 18,
Issue - 1,
Year - 2025
ABSTRACT:
Introduction: Ciprofloxacin, a broad-spectrum fluoroquinolone antibiotic, exhibits low aqueous solubility and limited oral bioavailability, classified as BCS class IV. Various strategies, including lipid-based drug delivery systems, have been explored to enhance its solubility. Our study aims to develop a novel Self-Microemulsifying Drug Delivery System (SMEDDS) for ciprofloxacin, with the goal of improving its clinical efficacy. Methods: The study conducted solubility assessments of ciprofloxacin in various oils, surfactants, and co-surfactants, followed by the establishment of a pseudo-ternary phase diagram to identify microemulsion regions. SMEDDS were then formulated based on the diagram's outcomes. These formulations underwent thermodynamic stability analyses and emulsification time assessments, alongside droplet size and zeta potential analyses to evaluate their characteristics. Results: Argan oil, Labrafac, and PEG 200 were identified as the excipients with the highest solubility, facilitating the development of SMEDDS formulations. Pseudoternary phase diagrams helped determine the optimal concentrations of oil, surfactant, and co-surfactant for microemulsion formation. Formulations within the SMEDDS region showed no phase separation or drug precipitation. Stability assessments revealed no significant changes due to temperature fluctuations. Emulsification studies indicated improved self-emulsifying properties with increasing surfactant proportions. Droplet size and zeta potential analyses showed characteristics consistent with SMEDDS formulations, with droplet sizes typically between 100 nm and 250nm, and stable zeta potential values exceeding +/-30mV. Conclusion: Formulating and evaluating a SMEDDS for ciprofloxacin, with argan oil as an excipient, revealed favorable physicochemical traits, including enhanced solubility and stability. This promising approach holds potential for optimizing ciprofloxacin delivery, with implications for future drug formulation advancements.
Cite this article:
Ismail Bennani, Ali Cherif Chefchaouni, Safae Alaoui, Badreddine Moukafih, Soufiane El Marrakchi, Fatima-Zahra Bandadi, Youssef Hafidi, Younes Rahali, Abdeslam El Kartouti. Formulation and Evaluation of Ciprofloxacin SMEDDS with Argan Oil: A Promising approach for Improved Drug Delivery. Research Journal of Pharmacy and Technology. 2025;18(1):312-6. doi: 10.52711/0974-360X.2025.00048
Cite(Electronic):
Ismail Bennani, Ali Cherif Chefchaouni, Safae Alaoui, Badreddine Moukafih, Soufiane El Marrakchi, Fatima-Zahra Bandadi, Youssef Hafidi, Younes Rahali, Abdeslam El Kartouti. Formulation and Evaluation of Ciprofloxacin SMEDDS with Argan Oil: A Promising approach for Improved Drug Delivery. Research Journal of Pharmacy and Technology. 2025;18(1):312-6. doi: 10.52711/0974-360X.2025.00048 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-1-48
REFERENCES:
1. Kumar, P, Chaudhary M, Juyal V. Difference Spectroscopy Validated Method Development for Ciprofloxacin in Tablet by UV-Spectrophotometer. Research Journal of Pharmacy and Technology. 2009; 2(4): 780-782
2. Caço A-I, Varanda F, Pratas de Melo M-J, Dias A-M-A, Dohrn R, Marrucho I-M. Solubility of Antibiotics in Different Solvents. Part II. Non-Hydrochloride Forms of Tetracycline and Ciprofloxacin. Ind. Eng. Chem. Res. 2008; 47: 8083–8089. doi: 10.1021/ie8003495.
3. Olivera M-E, Manzo R.H., Junginger H.E., Midha K-K, Shah V.P., Stavchansky S, Dressman J-B, Barends D-M. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ciprofloxacin Hydrochloride. J. Pharm. Sci. 2011; 100: 22–33. doi: 10.1002/jps.22259.
4. Raval A-J, Patel M-M. Techniques to Improve Bioavailability of Poorly Water Soluble Drugs–A review. Research Journal of Pharmaceutical Dosage Forms and Technology. 2011; 3(5): 183-192
5. Patil P, Mahajan, V-R. Self-Emulsifying Drug Delivery Systems (SEDDS): A Brief Review. Research Journal of Pharmaceutical Dosage Forms and Technology. 2014; 6(2): 134-139.
6. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Reviews. 2003; 55(3): 329–347. doi: 10.1016/S0169-409X(02)00228-4
7. Shrestha H, Bala R, Arora S. Lipid-Based Drug Delivery Systems. J Pharm (Cairo). 2014;2014:801820. doi: 10.1155/2014/801820.
8. GuruduttaP, Parmar J-U, SajidA-M, TahirA-M. Self-emulsifying drug delivery systems: An attempt to improve oral absorption of poorly soluble drugs. Research Journal of Pharmaceutical Dosage Forms and Technology. 2010; 2(3): 206-214
9. Sarode S-M, ChaudhariM-A, Kale M-K,VidyasagarG. Preparation and Characterization of Self Emulsifying Drug Delivery System (SEDDS). Research Journal of Pharmaceutical Dosage Forms and Technology. 2010; 2(4): 290-294.
10. Wei Y, Ye X, Shang X, et al. Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS). Colloids Surf A PhysicochemEngAspects. 2012; 396: 22–8. https://doi.org/10.1016/j.colsurfa.2011.12.025
11. Potphode V-R, DeshmukhA-S, MahajanV-R. Self-micro emulsifying drug delivery system: an approach for enhancement of bioavailability of poorly water soluble drugs. Asian Journal of Pharmacy and Technology. 2016; 6(3): 159-168. doi: 10.5958/2231-5713.2016.00023.4
12. MostafaS, El-SadekM, AllaE-A. Spectrophotometric determination of ciprofloxacin, enrofloxacin and pefloxacin through charge transfer complex formation. Journal of Pharmaceutical and Biomedical Analysis. 2002; 27(1-2): 133-142. doi: 10.1016/s0731-7085(01)00524-6
13. V. B. Borhade. Study of specialized emulsions for drug delivery (Masters thesis). University of Mumbai, India, 2006.
14. R. N. Gursoy and S. Benita. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 2004; 58: 173–182. doi: 10.1016/j.biopha.2004.02.001
15. GoikU, GoikT, ZałęskaI. The properties and application of argan oil in cosmetology. European Journal of Lipid Science and Technology. 2019; 121(4): 1800313. doi:10.1002/ejlt.201800313
16. Shambhu Dokania & Amita K. Joshi. Self-microemulsifying drug delivery system (SMEDDS) – challenges and road ahead. Drug Delivery. 2015; 22(6): 675-690. doi: 10.3109/10717544.2014.896058
17. T. Kommuru, B. Gurley, M. Khan, et al., Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment, Int. J. Pharm 2001; 212(2): 233-46. doi: 10.1016/s0378-5173(00)00614-1.
18. C.W. Pouton, Formulation of self-emulsifying drug delivery systems, Adv. Drug Deliv. Rev. 1997; 25(1): 47–58. doi:10.1016/S0169-409X(96)00490-5
19. S.A. Charman, W.N. Charman, M.C. Rogge, et al., Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound, Pharmaceut. Res. 1992; 9(1): 87-93. doi: 10.1023/a:1018987928936.
20. Gershanik, T.; Benzeno, S.; Benita, S. Interaction of a self-emulsifying lipid drug delivery system with the inverted rat intestinal mucosa as a function of droplet size and surface charge. Pharm. Res1998; 15(6): 863-9. doi: 10.1023/a:1011968313933.
21. Czajkowska-Kośnik A, Szekalska M, Amelian A, Szymańska E, Winnicka K. Development and Evaluation of Liquid and Solid Self-Emulsifying Drug Delivery Systems for Atorvastatin. Molecules. 2015; 20(12): 21010-22. doi: 10.3390/molecules201219745.
22. Gao P, Rush BD, Pfund WP. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci. 2003; 92(12): 2386-98. doi: 10.1002/jps.10511.
23. Gao P, Rush BD, Pfund WP. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J PharmSci. 92: 2386–98. doi: 10.1002/jps.10511
24. Sander C, Holm P. Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation. AAPS PharmSciTech. 2009; 10(4): 1388-95. doi: 10.1208/s12249-009-9340-0.
25. WarkeS, Warke-P, KaleM-K, SainiV. Formulation Design and Evaluation of Herbal Self Micro Emulsifying Drug Delivery System (SMEDDS). Research Journal of Pharmacy and Technology. 2011; 4(7): 1135-1140
26. Khansili A, BajpaiM. Formulation, evaluation and characterization of solid self-micro emulsifying drug delivery system (solid SMEDDS) containing nifedipine. Research Journal of Pharmacy and Technology. 2013; 6(3): 278-284
27. Dhairyasheel G, Adhikrao Y,Varsha G. Design and development of solid self-microemulsifying drug delivery of gefitinib. Asian Journal of Pharmacy and Technology. 2018; 8(4): 193-199
28. PawarP-P, PhadtareD-G. UV Spectrophotometric Method Development and Validation of Lornoxicam Loaded Solid SMEDDS. Research Journal of Pharmaceutical Dosage Forms and Technology. 2016; 8(4): 269-272.
29. Ponnaganti H, AbbuluK. Enhanced dissolution of repaglinide: SMEDDS formulation and in-vitro evaluation. Research Journal of Pharmacy and Technology. 2014; 7(11): 1246-1252.